Publicaciones en las que colabora con Marta Concheiro Guisán (28)

2021

  1. Assessment of biological matrices for the detection of in utero cannabis exposure

    Drug Testing and Analysis, Vol. 13, Núm. 7, pp. 1371-1382

2020

  1. LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium

    Journal of analytical toxicology, Vol. 44, Núm. 6, pp. 580-588

2019

  1. A LC-MS/MS method for the determination of common synthetic cathinones in meconium

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1124, pp. 349-355

  2. Detection of in utero ethanol exposure via ethyl glucuronide and ethyl sulfate analysis in umbilical cord and placenta

    Forensic Toxicology, Vol. 37, Núm. 1, pp. 90-103

2018

  1. Detection of in utero cannabis exposure by umbilical cord analysis

    Drug Testing and Analysis, Vol. 10, Núm. 4, pp. 636-643

  2. Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of nicotine and its metabolites in placenta and umbilical cord

    Drug Testing and Analysis, Vol. 10, Núm. 8, pp. 1305-1314

2017

  1. ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy

    Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474

  2. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy

    Drug Testing and Analysis, Vol. 9, Núm. 6, pp. 898-904

  3. Development and validation of a liquid chromatography tandem mass spectrometry method for the determination of cannabinoids and phase I and II metabolites in meconium

    Journal of Chromatography A, Vol. 1497, pp. 118-126

2013

  1. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection

    Therapeutic Drug Monitoring, Vol. 35, Núm. 4, pp. 502-509

  2. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy

    Therapeutic Drug Monitoring, Vol. 35, Núm. 3, pp. 296-304

  3. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS

    Analytical and Bioanalytical Chemistry, Vol. 405, Núm. 12, pp. 4295-4305

2012

  1. Hair analysis interpretation of an unusual case of alleged scopolamine-facilitated sexual assault

    Forensic Toxicology, Vol. 30, Núm. 2, pp. 193-198

  2. Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMS

    Forensic Science International, Vol. 217, Núm. 1-3, pp. 207-215

2009

  1. Ethylglucuronide determination in urine and hair from alcohol withdrawal patients

    Journal of Analytical Toxicology, Vol. 33, Núm. 3, pp. 155-161

2008

  1. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry

    Analytical and Bioanalytical Chemistry, Vol. 391, Núm. 6, pp. 2329-2338

  2. LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 48, Núm. 1, pp. 183-193

2007

  1. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing

    Forensic Science International, Vol. 170, Núm. 2-3, pp. 156-162

  2. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion

    Journal of Analytical Toxicology, Vol. 31, Núm. 9, pp. 573-580

  3. Fast LC-MS/MS method for the determination of amphetamine, methamphetamine, MDA, MDMA, MDEA, MBDB and PMA in urine

    Forensic Science International, Vol. 171, Núm. 1, pp. 44-51